CurrentCignaPolicy 1605

Medication Administration Site of Care

Defines medical necessity criteria determining when injectable medications should be administered in a hospital outpatient or hospital-affiliated infusion setting versus less intensive sites (e.g., home or non-hospital infusion) for Cigna-administered health benefit plans.

Policy Summary

PayerCigna

PolicyMedication Administration Site of Care

Policy CodePolicy 1605

Change TypeMaterial — scope clarification (added)

Effective DateMar 15, 2024

Next Review Date

Key ActionObtain prior authorization per the medication's coverage policy and document medical necessity for the requested site of care.

SourceLink

POLICY UPDATE CHANGES

Requests initiated from an out-of-network provider are explicitly included in the one-time 30 day approval period to facilitate transition to a less intensive site of care if medically necessary.

30-dayone-time approval period

3document pages

1605policy number

3/15/2024effective / last review

Coverage Criteria for Site of Care

Hospital outpatient or hospital-affiliated infusion coverage criteria

Cigna covers injectable treatment in a hospital outpatient setting or hospital-affiliated infusion suite as medically necessary for an individual with ANY of the following:

Hospital-site medical necessity criteria

The prescribed medication has a site of care restriction for administration per the FDA-approved label.
A documented history of an adverse event warranting a more intense level of care during or following infusion of the prescribed medication unless the adverse event can be appropriately managed by the use of pre-medication(s) or other preventive actions.
A documented history of a significant comorbidity (e.g., cardiopulmonary disorder) or concerns regarding fluid overload status that precludes treatment at an alternative less intensive site of care.

Alternative less intensive site expectation

Policy Summary

PayerCigna

PolicyMedication Administration Site of Care

Policy CodePolicy 1605

Change TypeMaterial — scope clarification (added)

Effective DateMar 15, 2024

Next Review Date

Key ActionObtain prior authorization per the medication's coverage policy and document medical necessity for the requested site of care.

SourceLink

On This Page

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Administration in a hospital outpatient setting or hospital-affiliated infusion suite may be considered not medically necessary when none of the hospital-site medical necessity criteria are met — specifically, when the medication does not have an FDA site-of-care restriction, there is no documented history of an adverse event requiring a higher level of care that cannot be managed with pre-medication or preventive measures, and there is no documented significant comorbidity (e.g., cardiopulmonary disorder) or fluid overload concern that precludes treatment at a less intensive site. When those criteria are absent, an alternative less intensive site of care should be utilized.

Provider Actions and Requirements

Denial Risk

Denial risk when criteria unmet

Coverage is expected to be denied when the medical necessity criteria for administration of an injectable medication in a hospital outpatient setting or hospital-affiliated infusion suite are not met. Providers should confirm that the requested site of care meets one or more of the policy’s hospital-setting criteria (e.g., FDA site-of-care restriction, documented prior adverse event requiring higher level care, or significant comorbidity that precludes less intensive settings) before submitting a request.

Denial expected if criteria for hospital outpatient/hospital-affiliated infusion suite are not met
Requests from hospital outpatient or out-of-network providers may be subject to a one-time 30-day approval to facilitate transition to a less intensive site of care

Documentation Required

Required supporting documentation

Providers must submit documentation to support the medical necessity of the requested hospital outpatient or hospital-affiliated infusion site of care. Supporting documentation may include, but is not limited to: clinical notes describing the patient’s condition and comorbidities, history of prior infusion-related adverse events (including severity and treatment required), documentation of FDA-labeled site-of-care restriction for the prescribed medication, and any information about attempted or unsuitable alternative less intensive sites (e.g., home infusion, ambulatory infusion center, physician office).

Clinical history and relevant comorbidities (e.g., cardiopulmonary disorders, fluid overload concerns)
Documentation of prior infusion-related adverse events and why pre-medication or preventive measures are insufficient
Copy or citation of FDA site-of-care restriction when applicable
If applicable, documentation of outpatient/home infusion contraindication or attempted transition efforts

Step Therapy

Step therapy guidance

Step therapy and medication-specific coverage policies remain primary for establishing medication medical necessity. Prior authorization or site-of-care determination for administration is linked to the medication’s coverage policy; providers should first consult the applicable medication A–Z coverage policy and the Specialty Care Options / Specialty Care Options Plus drug lists and FAQs to determine any medication-specific step therapy, site-of-care restrictions, or coverage requirements.

Refer to the medication’s A–Z coverage policy for injectable medication medical necessity criteria
Check Specialty Care Options and Specialty Care Options Plus drug lists for medications included in the site-of-care program and any step therapy requirements
Site-of-care prior authorization and medication coverage requirements are linked—ensure medication-specific prior authorization/step requirements are satisfied before or with site-of-care request

Site of Care Guidance

Note

Default to least intensive appropriate site of care

Administer injectable medications in the least intensive appropriate setting; hospital outpatient or hospital-affiliated infusion is covered only when specific criteria are met. If none of the hospital-site criteria apply, use a non-hospital outpatient infusion site (e.g., ambulatory infusion center or physician office) or home infusion. A one-time 30‑day approval may be granted for transition when the request originates from a hospital outpatient setting or an out-of-network provider.

Hospital outpatient / hospital-affiliated infusion: covered only with FDA site-of-care restriction, documented prior adverse event requiring higher-level care, or significant comorbidity/fluid overload concerns
Non-hospital outpatient infusion (ambulatory infusion center or physician office) and home infusion are the preferred less intensive sites
One-time 30-day transition approval may be provided for hospital/out-of-network initiated requests

Definitions

Alternative less intensive site of care — definition and examples

DefinitionNon-hospital affiliated outpatient infusion (e.g., ambulatory infusion center or physician office) or home infusion.

ExamplesAmbulatory infusion center; physician office infusion; home infusion services.

Use expectationPreferred when hospital-site medical necessity criteria are not present; the least intensive appropriate setting should be used.

Fallback policyWhen hospital-site criteria are unmet, an alternative less intensive site of care should be utilized.

Hospital outpatient setting or hospital-affiliated infusion suite — definition and expectations

DefinitionA hospital outpatient setting or hospital-affiliated infusion suite is a setting expected to have immediate access to emergency resuscitation equipment and personnel (ACLS protocol), emergency services, and inpatient admission or intensive care if necessary.

Expected capabilitiesImmediate access to emergency resuscitation equipment and ACLS-trained personnel.

Additional resourcesOn-site emergency services and ability to admit to inpatient or intensive care when required.

When requiredCovered for injectable administration when FDA site-of-care restriction, prior adverse event requiring higher-level care, or significant comorbidity/fluid overload concerns are present.

OpenPayer

Medication Administration Site of Care

Coverage Criteria for Site of Care

Provider Actions and Requirements

Site of Care Guidance

Definitions

Background